Riley Children's Health Annual Report 2022 – 2023

Expert neurologists at Riley Children’s Health use the latest tools and therapies to diagnose and treat the most complex neurologic disorders in children. Our team, which includes 17 pediatric neurologists, five advanced practice providers and a genetic counselor, facilitates numerous specialized multidisciplinary services, including programs for muscular dystrophy and refractory epilepsy. NEUROLOGY

RESEARCH HIGHLIGHTS

■ Translational research grant to study the effects of new migraine therapies on bone health ■ Artificial intelligence analysis of electroencephalogram tracings and movement patterns in childhood neurologic diseases ■ Clinical trials – Next generation migraine therapies in adolescents – Clinical trials for spinal muscular atrophy and muscular dystrophies ■ Evaluation of cholinergic markers in children with and without autism and Fragile X syndrome

DIVISION CHIEF Christopher T. Jackman, MD Associate Professor of Clinical Neurology, IU School of Medicine > Connect with Dr. Jackman on Doximity. >

Program distinctions

The MDA clinic at Riley Children’s has recently expanded to offer novel gene therapies for spinal muscular atrophy and Duchenne muscular dystrophy.

■ Ranked among the top pediatric neurology programs in the nation by U.S. News & World Report

17 board certified physicians

>

■ Muscular Dystrophy Association Care Center, recognizing clinical care and research

See full team member list

Neurology Volume: 2022 3,353 new patients

14,323 total patient visits

3,027 EEG studies performed

■ Accredited by the National Association of Epilepsy Centers as a Level 4 Comprehensive Epilepsy Center

NOTABLE PUBLICATIONS

■ Only facility in Indiana with:

Pediatric Neurology: January 2022 Fetal Cerebral Sinovenous Thrombosis and Dural Sinus Malformation Biological Psychiatry: March 2022 Crossing the “Birth Border” for Epigenetic Effects Journal of Child Neurology: March 2023 A Standardized, 3-Tiered, Seizure Burden-Based Protocol for the Treatment of Neonatal Seizures

Leading-edge technologies ■ Responsive neurostimulator system (RNS) placement ■ Stereo EEG ■ Laser ablation ■ Gene therapy for Duchenne muscular dystrophy Riley’s EEG laboratory and its long-term EEG monitoring program are accredited by ABRET Neurodiagnostic Credentialing and Accreditation.

– Neurofibromatosis Program – Tuberous Sclerosis Program – Neonatal Neurology Program – Advanced surgical epilepsy program – MDA clinic – Pediatric Headache Center – Neurogenetics Program

Specialized programs Pediatric Headache Center

Neurofibromatosis Program Provides multispecialty care for patients as a collaboration among neurology, hematology/oncology, genetics and dermatology; engaged in leading-edge research on medical therapies to help patients with aggressive or difficult-to- treat tumors.

Advanced treatment for pediatric epilepsy

Our comprehensive headache center offers next generation medications for refractory headache disorders. Collaborating with neurointerventional radiology specialists, we provide evaluation and treatment of complex cerebrospinal fluid disorders. Neonatal Neurology Program We provide specialized multidisciplinary neurologic care for term and preterm infants with neurologic disease and complications.

Riley Children’s offers the full range of surgical evaluations and treatments for epilepsy. In cooperation with Riley pediatric neurosurgeons, our neurologists work diligently to improve identification and surgical treatment of epilepsy patients with medically refractory epilepsy.

Refer a patient online

Annual Report 2022 – 2023

317.948.7450

Made with FlippingBook. PDF to flipbook with ease